Financials in USD. Standardized financial statements.
A compact view of how Avisa Diagnostics Inc. turns revenue into operating income and net income.
| Metric | FY 2020 | FY 2019 |
|---|---|---|
| Revenue? | $277,830 | $858,359 |
| Revenue Growth? | -67.6% | 0.0% |
| Cost of Revenue? | $148,549 | $2.80M |
| Gross Profit? | $129,281 | -$1.94M |
| Gross Margin? | +46.5% | -226.6% |
| Operating Expenses? | $1.03M | $787,192 |
| Operating Income? | -$900,655 | -$2.73M |
| EBITDA? | -$678,641 | -$3.24M |
| Income Before Tax | -$715,762 | -$4.23M |
| Income Tax Expense | $0 | -$2,050 |
| Net Income? | -$715,762 | -$4.13M |
| EPS? | $-0.14 | $-0.86 |
| Diluted EPS? | $-0.14 | $-0.86 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality